Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02101463 · ClinicalTrials.gov registry record · NA
MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts
A NA study, sponsored by Northside Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02101463 is a NA study that was terminated before completion, run by Northside Hospital. The registered enrollment target is 26 participants.
The verdict
NCT02101463, a NA study, was terminated before completion, sponsored by Northside Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This trial evaluates surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) for Abdominal Aortic Aneurysms (AAA) that are custom-made intra-operatively with no waiting period by a qualified vascular surgeon. In addition, it aims to examine the alternative sm-FBSG for patients with restricted access to centers performing clinical trials with commercially available devices and those patients with aortic emergencies.
Interventions
- DEVICE surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-08-28 |
| Est. Completion | 2015-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02101463
The ClinicalTrials.gov registry entry for NCT02101463 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northside Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) is the first listed.
NCT02101463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02101463 about?
NCT02101463 is a clinical study titled "MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts". This trial evaluates surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) for Abdominal Aortic Aneurysms (AAA) that are custom-made intra-operatively with no waiting period by a qualified vascular surgeon. In addition, it aims to examine the alternative sm-FBSG for patients with restricted a...
What is the current status of trial NCT02101463?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2012-08-28. Estimated completion is 2015-12-08.
What interventions are being tested in trial NCT02101463?
The interventions under investigation include: surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) (DEVICE).
Who is sponsoring clinical trial NCT02101463?
This trial is sponsored by Northside Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.